Nissan Chemical, · Nissan Chemical, ‐where unique & solution meet Confidential 4.9 4.5 11.3 12.0...

Nissan Chemical, ‐where unique & solution meet

Long-term Business Plan ”Progress2030” Mid-term Business Plan “Vista2021”

May 12, 2016

Translation of presentation materials for the investor meeting held in Tokyo on May 12, 2016


Confidential

Contents

2


1. “Vista2015 StageⅡ” :Review


Confidential 4

19.6

22.0

26.0

0

10

20

30

2013 2014 2015

Basic strategies of StageⅡ


Confidential

Financial results(vs. Plan)

5

Net Sales OP

19.6

22.0

26.0

22.2

25.3

28.6 156.0

170.0

180.0

163.7 171.2

176.9

0

5

10

15

20

25

30

35

40

0

50

100

150

200

2013 2014 2015

OP（Plan） OP（Actual） Sales（Plan） Sales（Actual）


Confidential

4.9 4.5

11.3 12.0

7.6 10.8

3.5

1.4

-1.3 -0.1

-5

0

5

10

15

20

25

30

Plan Actual

Chemicals Performance Agro Pharma Others6

26.0 28.6

Former segmentation basis

Financial results(vs. Plan)

Others: Trading, Others, Adjustment

Performance Mat. +0.7

Display materials: Sales expansion in smartphone use

Agrochemicals +3.2

Fluralaner, ALTAIR and ROUNDUP: Steady growth

Pharma -2.1

LIVALO: Decreased due to generics gaining market share

Others +1.2

Chemicals -0.4

High purity sulfuric acid and TEPIC for electronic materials: Decreased


Confidential

Financial Indicators(vs. Plan)

7

Plan Actual

OP margin 14.4% 16.2%

ROE 13.4% 14.6%

R&D expenses / Sales ratio 9.6% 8.9%

Dividend payout ratio Over 30% 30.7%


Confidential 8

Creating new Businesses & new products

（FCeM® preparation kit) （Materials Research Lab）


Confidential 9

Pursuit of business structure reforms

Kanazawa City Toyama City

Ishikawa

Natural Gas Pipeline

NCI Toyama Plant

Sea of Japan

Niigata

Toyama

Naoetsu LNG

Terminal of INPEX

Itoigawa City


Confidential

0

100

200

300

400

0

500

1000

1500

2000

2013 2014 2015

10

Towards the future growth


Confidential 11

New business plans

We strive to create better future for human and environment by helping to solve social issues


Confidential 12

Business model


2. “Progress2030” : Outline


Confidential

Long-term perspective

Diversity

Advanced

medical care

Longevity

/Aging

Food

shortages

Speeding up

data communication

Energy

problems

Global

environmental protection

Medical

inflation

Business environment

2030 vision

14


Confidential 15

Business domains

Fine Organic

Synthesis

Functional Polymer Design Ultrafine

Particle Control

Biological Evaluation

Optical Control

Core Technologies

Life Sciences Information &

Communication

Environment & Energy

Chemicals & Affiliates


Confidential 16

Basic strategy


Confidential 17

Information & Communication

Establishing

optical control technologies

（Image of optical interconnect）


Confidential 18

Life Sciences

Creating biomedical materials

（Dialysis machine）


Confidential 19


Establishing a device

evaluation technology

（Lithium-ion battery）


Confidential 20


Introducing

high-performance compounds


Confidential 21

Business scale

Fine Organic

Synthesis


Particle Control


Optical Control

Core Technologies


Communication



Sensor materials Optical functional

materials Biomedical materials

Display materials Semiconductor

materials

Inorganic materials

Veterinary pharmaceuticals

Pharmaceuticals

Agrochemicals

Battery materials Energy harvesting

materials Thermal control

materials

High-performance compound

Affiliates Basic chemicals

Fine chemicals


Confidential 22

Business scale

Fine Organic

Synthesis


Particle Control


Optical Control

Core Technologies


Communication




3. “Vista2021” : Outline

StageⅠ（2016~2018） StageⅡ（2019~2021）


Confidential 24

Ideal situation of 2021


Confidential 25

34.3 35.4 38.0 40.5

51.8 55.3 68.0

82.9

47.5 52.1

58.6

67.0

8.7 7.4

8.1

8.3

34.6 37.3

44.3

51.3

0

50

100

150

200

250

300

2015 2016 2018 2021

Chemicals Performance Agro Pharma Others

176.9

217.0

250.0

Pharma FY18 vs. FY15 -0.6 FY21 vs. FY15 -0.4

Agrochemicals FY18 vs. FY15 +11.1 FY21 vs. FY15 +19.5

Performance Mat. FY18 vs. FY15 +16.2 FY21 vs. FY15 +31.1

Chemicals FY18 vs. FY15 +3.7 FY21 vs. FY15 +6.2

Naphtha（¥/KL）: FY2015 42,800 FY2016 35,400 FY2017 onward 51,100 FX rate（¥/$）:FY2015 1H 122 2H 118 FY2016 onward 115

187.5

Billion yen

Others FY18 vs. FY15 +9.7 FY21 vs. FY15 +16.7

Target: Net sales



Confidential 26

3.9 4.9 4.0 4.5

12.0 11.7 15.4 18.4

10.8 11.3

12.9

16.7

2.0 1.4

2.0

2.4

-0.1

0.4

0.7

-2.0

-5

0

5

10

15

20

25

30

35

40

45

2015 2016 2018 2021

Chemicals Performance Agro Pharma Others

28.6

35.0

40.0

Pharma FY18 vs. FY15 0 FY21 vs. FY15 +0.4

Agrochemicals FY18 vs. FY15 +2.1 FY21 vs. FY15 +5.9

Performance Mat. FY18 vs. FY15 +3.4 FY21 vs. FY15 +6.4

Chemicals FY18 vs. FY15 +0.1 FY21 vs. FY15 +0.6

29.7

Target: OP

Others FY18 vs. FY15 +0.8 FY21 vs. FY15 -1.9

Naphtha（¥/KL）: FY2015 42,800 FY2016 35,400 FY2017 onward 51,100 FX rate（¥/$）:FY2015 1H 122 2H 118 FY2016 onward 115


Billion yen


Confidential

20.4

24.3

14.9 20.8

18.9

22.3

5.8

11.8

5.7

7.2

8.1

10.1

0

10

20

30

40

50

13-15 16-18 13-15 16-18

Performance Mat. Life Sciences Others 27

165 184 194

174 172 169

74 72

85

0

100

200

300

400

500

2015 2016 2018Performance Mat. Life Sciences Corporate

413 428

448

Three year total Capex： FY13-15 Acceptance basis FY16-18 Production commencement basis

45.0

28.8

53.8

42.7

Person Billion yen

Resource allocation


4. “StageⅠ(FY2016～2018)” : Outline


Confidential

StageⅠ 2016-2018

StageⅡ 2019-2021

2030

29

Basic strategies


Confidential

Sources of growth

30

Chemicals

（AdBlue® container) （LED）


Confidential 31

Performance Materials

ITO electrode

Microlens

Sources of growth

Wiring


Confidential 32

Agrochemicals

Sources of growth


Confidential 33

Pharmaceuticals

（Research instruments）

Sources of growth


Confidential

Initiatives for 2019 onwards

34

Information & Communication

（Automotive window）（Image of a photo shoot with smartphone）


Confidential 35

Life Sciences

（FCeM® series）（SphereMaxTM）



Confidential 36


（Solar panel）



Confidential 37

R&D

（Collaboration with Kyushu University)



Confidential

Financial indicators

38

FY2015 Actual

FY2018 Target

OP margin 16.2% 15% or higher

ROE 14.6% 14% or higher

R&D expenses / Sales ratio

8.9% 8% or higher

Dividend payout ratio 30.7% 40%

Total payout ratio 70.8% Maintaining

70%

Information &

Communication

Life Sciences

Environment &

Energy

Business domain Core technologies

Fine Organic Synthesis

Functional Polymer Design

Ultrafine Particle Control


Optical Control

Supply agrochemicals

Provide veterinary pharmaceuticals

Develop pharmaceuticals

Create biomedical materials

Supply battery materials

Develop energy harvesting materials

Create thermal control materials

Supply display and semiconductor materials

Offer sensor materials

Develop optical interconnect materials

Promote Responsible Care activities

Respect individuality and create friendly working environment

Strengthen corporate governance and make proper disclosure

Food shortages

Energy demand rise

Reduce environmental load

Enhance well-being

Advanced medical care

ICT evolution

Global environmental protection

Diversity

Sensible business activity

Create new technologies and products that respond to visible/potential

social needs

Che

mic

als & A

ffiliates

39


Confidential 40

Forward Looking Statements

The forward looking statements in this material are based on information available at the time of preparation of the material. Although they reflect our current expectations, these statements are not guarantees of future performance, but include a number of risks and uncertainties. Actual results may largely differ from these statements due to various factors which may be beyond company control. No information in this material is provided as an offer to buy or sell the shares of the company. We urge users of the material to make investment decision based upon own judgment.

Date post:	23-Sep-2020
Category:	Documents
Upload:	others
View:	0 times
Download:	0 times

Nissan Chemical, · Nissan Chemical, ‐where unique & solution meet Confidential 4.9 4.5 11.3 12.0...

Documents